These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36864784)

  • 1. Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS.
    Yang Y; Brown MC; Zhang G; Stevenson K; Mohme M; Kornahrens R; Bigner DD; Ashley DM; López GY; Gromeier M
    Neuro Oncol; 2023 Sep; 25(9):1631-1643. PubMed ID: 36864784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
    Chandramohan V; Bryant JD; Piao H; Keir ST; Lipp ES; Lefaivre M; Perkinson K; Bigner DD; Gromeier M; McLendon RE
    Arch Pathol Lab Med; 2017 Dec; 141(12):1697-1704. PubMed ID: 28829151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Glioblastoma Treated with Recombinant Poliovirus.
    Desjardins A; Gromeier M; Herndon JE; Beaubier N; Bolognesi DP; Friedman AH; Friedman HS; McSherry F; Muscat AM; Nair S; Peters KB; Randazzo D; Sampson JH; Vlahovic G; Harrison WT; McLendon RE; Ashley D; Bigner DD
    N Engl J Med; 2018 Jul; 379(2):150-161. PubMed ID: 29943666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells.
    Walton RW; Brown MC; Sacco MT; Gromeier M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
    Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E
    Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models.
    Holl EK; Brown MC; Boczkowski D; McNamara MA; George DJ; Bigner DD; Gromeier M; Nair SK
    Oncotarget; 2016 Nov; 7(48):79828-79841. PubMed ID: 27806313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma.
    Beasley GM; Nair SK; Farrow NE; Landa K; Selim MA; Wiggs CA; Jung SH; Bigner DD; True Kelly A; Gromeier M; Salama AK
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33875611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy.
    Wang C; Chen Q; Chen M; Guo S; Hou P; Zou Y; Wang J; He B; Zhang Q; Chen L; Luo L
    Cancer Immunol Immunother; 2023 Jun; 72(6):1685-1698. PubMed ID: 36624155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
    Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Poliovirus for Cancer Immunotherapy.
    Gromeier M; Nair SK
    Annu Rev Med; 2018 Jan; 69():289-299. PubMed ID: 29414253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.
    Sugii N; Matsuda M; Okumura G; Shibuya A; Ishikawa E; Kaneda Y; Matsumura A
    Cancer Sci; 2021 Jan; 112(1):81-90. PubMed ID: 33155337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions.
    Liu J; Piranlioglu R; Ye F; Shu K; Lei T; Nakashima H
    Front Cell Infect Microbiol; 2023; 13():1141034. PubMed ID: 37234776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic polio virotherapy of cancer.
    Brown MC; Dobrikova EY; Dobrikov MI; Walton RW; Gemberling SL; Nair SK; Desjardins A; Sampson JH; Friedman HS; Friedman AH; Tyler DS; Bigner DD; Gromeier M
    Cancer; 2014 Nov; 120(21):3277-86. PubMed ID: 24939611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy.
    Khalique H; Baugh R; Dyer A; Scott EM; Frost S; Larkin S; Lei-Rossmann J; Seymour LW
    J Immunother Cancer; 2021 Mar; 9(4):. PubMed ID: 33820820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus.
    Brown MC; Gromeier M
    Curr Opin Virol; 2015 Aug; 13():81-5. PubMed ID: 26083317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
    Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Practical Consideration of Poliovirus as an Oncolytic Virotherapy.
    Denniston E; Crewdson H; Rucinsky N; Stegman A; Remenar D; Moio K; Clark B; Higginbotham A; Keffer R; Brammer S; Horzempa J
    Am J Virol; 2016; 5(1):1-7. PubMed ID: 28203321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic Virotherapy Blockade by Microglia and Macrophages Requires STAT1/3.
    Delwar ZM; Kuo Y; Wen YH; Rennie PS; Jia W
    Cancer Res; 2018 Feb; 78(3):718-730. PubMed ID: 29118089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.
    Brown MC; Holl EK; Boczkowski D; Dobrikova E; Mosaheb M; Chandramohan V; Bigner DD; Gromeier M; Nair SK
    Sci Transl Med; 2017 Sep; 9(408):. PubMed ID: 28931654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.